Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial

Purpose: Colonoscopy is often accompanied by short-term postoperative cognitive decline. We aimed to explore whether single-use alfentanil for patients undergoing elective colonoscopy could reduce cognitive impairment at discharge compared with propofol. Patients and methods: 172 adult patients unde...

Full description

Bibliographic Details
Main Authors: Xiwen Zhu, Xuehan Chen, Xuemei Zheng, Hongyao Lyu, Jie Chen, Ai Yan, Qi Liu, Shiqi Li, Yamei Zhang, Ting Wang, Guangyou Duan, He Huang
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402304269X
_version_ 1827923840908394496
author Xiwen Zhu
Xuehan Chen
Xuemei Zheng
Hongyao Lyu
Jie Chen
Ai Yan
Qi Liu
Shiqi Li
Yamei Zhang
Ting Wang
Guangyou Duan
He Huang
author_facet Xiwen Zhu
Xuehan Chen
Xuemei Zheng
Hongyao Lyu
Jie Chen
Ai Yan
Qi Liu
Shiqi Li
Yamei Zhang
Ting Wang
Guangyou Duan
He Huang
author_sort Xiwen Zhu
collection DOAJ
description Purpose: Colonoscopy is often accompanied by short-term postoperative cognitive decline. We aimed to explore whether single-use alfentanil for patients undergoing elective colonoscopy could reduce cognitive impairment at discharge compared with propofol. Patients and methods: 172 adult patients undergoing elective colonoscopy were randomized to receive intravenous propofol at 2 mg/kg (group P) or alfentanil at 10 μg/kg (group A); 40 healthy volunteers were included in the blank group. Cognitive function was considered the primary outcome and was measured using five neuropsychological tests before sedation and discharge. The z-score method was used to determine cognitive dysfunction according to z-score >1.96 in two types of neuropsychological tests. Other outcomes included discharge time, vital signs, associated adverse events during colonoscopy, and the satisfaction level of patients and endoscopic physicians. Results: 164 patients (78 in group A and 86 in group P) completed the study protocol. At discharge, the incidence of cognitive dysfunction in group P was 23% and was significantly lower in the alfentanil group (2.5%), with a relative risk of 0.11 (95% confidence interval: 0.03–0.46, P < 0.001). The incidence of hypotension in group A was lower than that in group P (3.8% vs 22.1%, relative risk = 0.17 [95% confidence interval: 0.05–0.46, P = 0.001]), and the discharge time in group A was shorter than that in group P (5 [(Rutter and et al., 2016; Zhang and et al., 2013; Hirsh and et al., 2006; Zhou and et al., 2021; Singh and et al., 2008; Ko and et al., 2010; Sargin et al., 2019) 3–93–9 vs 13 [(Ekmekci and et al., 2017; Eberl and et al., 2012; Eberl and et al., 2014; N'Kaoua and et al., 2002; Chung et al., 1995; Berger and et al., 2019; Quan and et al., 2019; Deng and et al., 2021; Gualtieri and Johnson, 2006) 10–1810–18 min, P < 0.001). Conclusion: For patients undergoing colonoscopy, single-use alfentanil causes less damage to postoperative cognitive function, less risk of hypotension, and shorter discharge time than propofol.
first_indexed 2024-03-13T05:01:55Z
format Article
id doaj.art-9b40699c80054cab9cfaeee27ccf8bc1
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-13T05:01:55Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-9b40699c80054cab9cfaeee27ccf8bc12023-06-17T05:19:30ZengElsevierHeliyon2405-84402023-06-0196e17061Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trialXiwen Zhu0Xuehan Chen1Xuemei Zheng2Hongyao Lyu3Jie Chen4Ai Yan5Qi Liu6Shiqi Li7Yamei Zhang8Ting Wang9Guangyou Duan10He Huang11Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, ChinaDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, ChinaDepartment of Preventive Medicine, West China School of Public Health, Sichuan University, Chengdu, Sichuan, ChinaDepartment of Preventive Medicine, West China School of Public Health, Sichuan University, Chengdu, Sichuan, ChinaDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, ChinaDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, ChinaDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, ChinaDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, ChinaDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, ChinaDepartment of Psychology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, ChinaDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China; Corresponding author.Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China; Corresponding author.Purpose: Colonoscopy is often accompanied by short-term postoperative cognitive decline. We aimed to explore whether single-use alfentanil for patients undergoing elective colonoscopy could reduce cognitive impairment at discharge compared with propofol. Patients and methods: 172 adult patients undergoing elective colonoscopy were randomized to receive intravenous propofol at 2 mg/kg (group P) or alfentanil at 10 μg/kg (group A); 40 healthy volunteers were included in the blank group. Cognitive function was considered the primary outcome and was measured using five neuropsychological tests before sedation and discharge. The z-score method was used to determine cognitive dysfunction according to z-score >1.96 in two types of neuropsychological tests. Other outcomes included discharge time, vital signs, associated adverse events during colonoscopy, and the satisfaction level of patients and endoscopic physicians. Results: 164 patients (78 in group A and 86 in group P) completed the study protocol. At discharge, the incidence of cognitive dysfunction in group P was 23% and was significantly lower in the alfentanil group (2.5%), with a relative risk of 0.11 (95% confidence interval: 0.03–0.46, P < 0.001). The incidence of hypotension in group A was lower than that in group P (3.8% vs 22.1%, relative risk = 0.17 [95% confidence interval: 0.05–0.46, P = 0.001]), and the discharge time in group A was shorter than that in group P (5 [(Rutter and et al., 2016; Zhang and et al., 2013; Hirsh and et al., 2006; Zhou and et al., 2021; Singh and et al., 2008; Ko and et al., 2010; Sargin et al., 2019) 3–93–9 vs 13 [(Ekmekci and et al., 2017; Eberl and et al., 2012; Eberl and et al., 2014; N'Kaoua and et al., 2002; Chung et al., 1995; Berger and et al., 2019; Quan and et al., 2019; Deng and et al., 2021; Gualtieri and Johnson, 2006) 10–1810–18 min, P < 0.001). Conclusion: For patients undergoing colonoscopy, single-use alfentanil causes less damage to postoperative cognitive function, less risk of hypotension, and shorter discharge time than propofol.http://www.sciencedirect.com/science/article/pii/S240584402304269XAlfentanilPropofolColonoscopyCognitive function
spellingShingle Xiwen Zhu
Xuehan Chen
Xuemei Zheng
Hongyao Lyu
Jie Chen
Ai Yan
Qi Liu
Shiqi Li
Yamei Zhang
Ting Wang
Guangyou Duan
He Huang
Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial
Heliyon
Alfentanil
Propofol
Colonoscopy
Cognitive function
title Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial
title_full Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial
title_fullStr Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial
title_full_unstemmed Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial
title_short Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial
title_sort effects of single use alfentanil versus propofol on cognitive functions after colonoscopy a randomized controlled trial
topic Alfentanil
Propofol
Colonoscopy
Cognitive function
url http://www.sciencedirect.com/science/article/pii/S240584402304269X
work_keys_str_mv AT xiwenzhu effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT xuehanchen effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT xuemeizheng effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT hongyaolyu effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT jiechen effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT aiyan effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT qiliu effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT shiqili effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT yameizhang effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT tingwang effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT guangyouduan effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT hehuang effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial